23-05-2025
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ('Wolf Haldenstein'), a distinguished law firm with over 125 years of history, announces it is
investigating claims on behalf of investors of P3 Health Partners, Inc. (NASDAQ: PIII) ('P3' or the 'Company'). (NASDAQ: PIII)
Allegations and Investigation Focus:
Triggering Events:
1. November 12, 2024 – P3 reported disappointing financial results in its Form 10-Q filed with the United States Securities and Exchange Commission (SEC):
2. March 28, 2025 – Annual Form 10-K disclosed:
Why Wolf Haldenstein Adler Freeman & Herz LLP?
This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.
We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.
Contact Information:
Firm: Wolf Haldenstein Adler Freeman & Herz LLP
Primary Contact: Gregory Stone, Director of Case and Financial Analysis
Email: [email protected] or [email protected]
Phone: (800) 575-0735 or (212) 545-4774
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
